These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 182723

  • 1. Aldosterone receptors and the evaluation of plasma mineralocorticoid activity in normal and hypertensive states.
    Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Taylor AA, Bartter FC.
    J Clin Invest; 1976 Sep; 58(3):579-89. PubMed ID: 182723
    [Abstract] [Full Text] [Related]

  • 2. Role of steroids in hypertension: evaluation of plasma mineralocorticoid activity with aldosterone receptors.
    Baxter JD, Schambelan M, Matulich DT, Spindler BJ, Bartter FC.
    Clin Sci Mol Med Suppl; 1976 Dec; 3():321s-324s. PubMed ID: 1071637
    [Abstract] [Full Text] [Related]

  • 3. Radioreceptor assay of plasma mineralocorticoid activity. Role of aldosterone, cortisol, and deoxycorticosterone in various mineralocorticoid-excess states.
    Lan NC, Matulich DT, Stockigt JR, Biglieri EG, New MI, Winter JS, McKenzie JK, Baxter JD.
    Circ Res; 1980 Jun; 46(6 Pt 2):I94-100. PubMed ID: 6991154
    [No Abstract] [Full Text] [Related]

  • 4. Are we missing a mineralocorticoid in teleost fish? Effects of cortisol, deoxycorticosterone and aldosterone on osmoregulation, gill Na+,K+ -ATPase activity and isoform mRNA levels in Atlantic salmon.
    McCormick SD, Regish A, O'Dea MF, Shrimpton JM.
    Gen Comp Endocrinol; 2008 May 15; 157(1):35-40. PubMed ID: 18462736
    [Abstract] [Full Text] [Related]

  • 5. Affinity of 18,19-dihydroxydeoxycorticosterone and 18-hydroxy-19-nor-deoxycorticosterone to aldosterone receptor and their mineralocorticoid activity.
    Okamoto M, Momoi K, Yamano T, Nakamura M, Odaguchi K, Shimizu T, Okada T, Terasawa T.
    Biochem Int; 1983 Dec 15; 7(6):687-94. PubMed ID: 6237653
    [Abstract] [Full Text] [Related]

  • 6. Relationship of basal plasma norepinephrine to blood pressure, plasma renin activity, mineralocorticoids, and plasma volume in essential hypertension.
    Chobanian AV, Gavras H, Melby JC, Gavras I, Jick H.
    Trans Assoc Am Physicians; 1978 Dec 15; 91():368-80. PubMed ID: 754399
    [Abstract] [Full Text] [Related]

  • 7. Mineralocorticoid receptors in human kidney.
    Matulich DT, Spindler BJ, Schambelan M, Baxter JD.
    J Clin Endocrinol Metab; 1976 Nov 15; 43(5):1170-4. PubMed ID: 993320
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma renin activity, aldosterone and cortisol levels during physical exercise in essential hypertension.
    Ignatowska-Switalska H, Wocial B, Skórka B, Chodakowska J, Nazar K, Chwalbińska-Moneta J.
    Acta Physiol Pol; 1980 Nov 15; 31(6):631-5. PubMed ID: 7018172
    [Abstract] [Full Text] [Related]

  • 11. [Rectal electrical potential difference and plasma aldosterone in hyperaldosteronism and low-, normal- and high-renin hypertension].
    Skrabal F, Mauser R.
    Wien Klin Wochenschr; 1976 Dec 10; 88(23):777-81. PubMed ID: 1014711
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Interaction of 16beta-hydroxydehydroepiandrosterone with renal mineralocorticoid receptors.
    Higgins JR, Wambach G, Kem DC, Gomez-Sanchez C, Holland OB, Kaplan NM.
    J Lab Clin Med; 1977 Feb 10; 89(2):250-6. PubMed ID: 137938
    [Abstract] [Full Text] [Related]

  • 15. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P, Fardella C, Oestreicher E, Gac H, Mosso L, Soto J, Foradori A, Claverie X, Ahuad J, Montero J.
    Rev Med Chil; 2000 Sep 10; 128(9):955-61. PubMed ID: 11349499
    [Abstract] [Full Text] [Related]

  • 16. Plasma cortisol and corticosteroid-binding globulin in essential hypertension.
    Nowaczynski W, Wilkins GE, Murakami T, Mavoungou D, Levin J.
    Clin Physiol Biochem; 1988 Sep 10; 6(2):82-94. PubMed ID: 2841062
    [Abstract] [Full Text] [Related]

  • 17. [Mechanism of primary hypertension].
    Kornel L, Prancan AV.
    Harefuah; 1998 Jun 01; 134(11):837-43, 920. PubMed ID: 10909653
    [Abstract] [Full Text] [Related]

  • 18. [Strategy for studying mineralocorticoids other than aldosterone in arterial hypertension of hormonal origin].
    Roger M, Nahoul K, Laloy E, Scholler R.
    Ann Med Interne (Paris); 1983 Jun 01; 134(3):238-41. PubMed ID: 6625419
    [Abstract] [Full Text] [Related]

  • 19. 16Beta-hydroxydehydroepiandrosterone: the dichotomy between renal receptor binding and urinary electrolyte activity.
    Funder JW, Robinson JA, Feldman D, Wynne KN, Adam WR.
    Endocrinology; 1976 Aug 01; 99(2):619-28. PubMed ID: 182463
    [Abstract] [Full Text] [Related]

  • 20. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
    Mosso L, Carvajal C, Campino C, Rojas A, González A, Barraza A, Montero J, Fardella C.
    Rev Med Chil; 2002 Nov 01; 130(11):1201-8. PubMed ID: 12587501
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.